Spatial Transcriptomics Capture Probes for Reliable Analyte Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods fail to provide spatially resolved data on analyte levels within tissues, and permeabilization conditions for releasing analytes are often unpredictable, affecting downstream capture and sequencing.

Innovation Solution

A method involving contacting a biological sample with capture probes, releasing target analytes, extending the capture probe using the bound analyte as a template, adding homopolynucleotide sequences, and using template switching oligonucleotides to measure fluorescence, allowing for spatial analysis of analytes like RNA or DNA.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional spatial analysis methods are used, then spatial location information is provided, but analyte capture sensitivity and specificity are insufficient

Engineering Contradiction:
Improvespatial location precisionVSAvoidanalyte capture reliability
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The capture probe is divided into distinct functional domains: a spatial barcode domain for location identification and a capture domain for analyte binding. This segmentation allows independent optimization of spatial resolution and capture efficiency, resolving the contradiction between providing precise spatial location and ensuring reliable analyte capture.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces an intermediary amplification step using template switching oligonucleotides and rolling circle amplification. This intermediary process enhances the signal from captured analytes, improving detection sensitivity without compromising the spatial location information provided by the barcode domain.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Quantity of substance

If permeabilization conditions are optimized for one tissue type, then analyte release is improved, but downstream capture and sequencing are affected

Engineering Contradiction:
Improveanalyte release quantityVSAvoiddownstream capture reliability
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent employs a systematic approach to optimize permeabilization parameters (time, temperature, reagent concentration) specifically for each tissue type. By tuning these parameters, the method maximizes analyte release while preserving analyte integrity for subsequent capture and sequencing, resolving the contradiction between release quantity and downstream capture reliability.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent performs preliminary permeabilization optimization for different tissue types before proceeding to capture and sequencing. This preliminary action ensures that the right permeabilization conditions are established beforehand, preventing downstream issues and ensuring reliable capture and sequencing of released analytes.

Inventive Principle:
Principle #10Preliminary action

3Reliability

If multiple permeabilization conditions are tested, then optimal conditions are identified, but time and resources are consumed

Engineering Contradiction:
Improvepermeabilization condition optimizationVSAvoidoptimization time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent incorporates feedback mechanisms where the results of permeabilization are monitored and used to adjust subsequent capture and sequencing parameters. This feedback loop allows for rapid optimization by learning from previous attempts, reducing the overall time and resources needed to identify optimal conditions for different tissue types.

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enhances the sensitivity and specificity of analyte capture and detection, enabling accurate spatial analysis of nucleic acids and proteins within tissues.

Implementation Method 1

measuring presence or absence of fluorescence upon release of the first oligonucleotide from the second oligonucleotide by extension of a 3′ end of the first strand using the second oligonucleotide as a template

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS12435363B1Materials and methods for spatial transcriptomics
Publication Date: 2025.10.07 10X GENOMICS INC
  • US12435363B1 patent drawing
  • US12435363B1 patent drawing
  • US12435363B1 patent drawing

AI summary

Provided herein are methods of determining efficiencies of spatial transcriptomics methods.